Skip to main content
. 2016 Dec 8;6:38498. doi: 10.1038/srep38498

Figure 5. Validation of targets for different miRNAs in KEGG ‘Pathways in cancer’.

Figure 5

(a–e) Confirmation of specific miRNA overexpression in transfected cells as compared with control cells. (f–h) Members of the CDK family found to be downregulated in has-miR-124-3p transfected cells. (i–n) Different cytokines and cytokine receptors targeted by different miRNAs. (o–t), Survival signaling-pathway molecules found to be downregulated following transfection of different miRNA as compared to negative-control cells. The experiments were repeated at least three times. *p < 0.05, **p < 0.01 and ***p < 0.001.